Seres Therapeutics
MCRB
MCRB
72 hedge funds and large institutions have $243M invested in Seres Therapeutics in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 27 increasing their positions, 15 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
8% less funds holding
Funds holding: 78 → 72 (-6)
11% less capital invested
Capital invested by funds: $274M → $243M (-$30.5M)
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
Holders
72
Holding in Top 10
1
Calls
$165K
Puts
$93K
Top Buyers
| 1 | +$5.88M | |
| 2 | +$309K | |
| 3 | +$192K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$190K |
| 5 |
Renaissance Technologies
New York
|
+$187K |
Top Sellers
| 1 | -$2.93M | |
| 2 | -$1.19M | |
| 3 | -$633K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$455K |
| 5 |
CEP
Chicago Equity Partners
Chicago,
Illinois
|
-$214K |